Click below to hear recorded audio for Frequently Asked Questions on this topic.
Why is sensitivity and specificity of importance when testing for LTBI in children?
Why the small amount of blood volume required to run the T-SPOT®.TB test would benefit the patient and the clinician?
Why would you consider that washing and standardization of cell counts is important to bear in mind when screening for LTBI in children?
Can you walk us through the latest recommendations and guidelines of latent TB screening in the pediatric population?
T-SPOT is a registered trademark of Oxford Immunotec Ltd.